Chemical modification patterns compatible with high potency Dicer-substrate small interfering RNAs

被引:69
作者
Collingwood, Michael A. [1 ]
Rose, Scott D. [1 ]
Huang, Lingyan [1 ]
Hillier, Chris [1 ]
Amarzguioui, Mohammad [2 ,3 ]
Wiiger, Merete T. [2 ]
Soifer, Harris S. [4 ,5 ]
Rossi, John J.
Behlke, Mark A. [1 ]
机构
[1] Integrated DNA Technol Inc, Coralville, IA 52241 USA
[2] Univ Oslo, Ctr Biotechnol, Oslo, Norway
[3] siRNAsense AS, Oslo, Norway
[4] Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA USA
[5] Beckman Res Inst City Hope, Grad Sch Biol Sci, Duarte, CA USA
关键词
D O I
10.1089/oli.2008.0123
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dicer-substrate small interfering RNAs (DsiRNAs) are synthetic RNA duplexes that are processed by Dicer into 21-mer species and show improved potency as triggers of RNA interference, particularly when used at low dose. Chemical modification patterns that are compatible with high potency 21-mer small interfering RNAs have been reported by several groups. However, modification patterns have not been studied for Dicer-substrate duplexes. We therefore synthesized a series of chemically modified 27-mer DsiRNAs and correlated modification patterns with functional potency. Some modification patterns profoundly reduced function although other patterns maintained high potency. Effects of sequence context were observed, where the relative potency of modification patterns varied between sites. A modification pattern involving alternating 2'-O-methyl RNA bases was developed that generally retains high potency when tested in different sites in different genes, evades activation of the innate immune system, and improves stability in serum.
引用
收藏
页码:187 / 199
页数:13
相关论文
共 47 条
[1]   Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA [J].
Allerson, CR ;
Sioufi, N ;
Jarres, R ;
Prakash, TP ;
Naik, N ;
Berdeja, A ;
Wanders, L ;
Griffey, RH ;
Swayze, EE ;
Bhat, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) :901-904
[2]   Tolerance for mutations and chemical modifications in a siRNA [J].
Amarzguioui, M ;
Holen, T ;
Babaie, E ;
Prydz, H .
NUCLEIC ACIDS RESEARCH, 2003, 31 (02) :589-595
[3]   Progress towards in vivo use of siRNAs [J].
Behlke, MA .
MOLECULAR THERAPY, 2006, 13 (04) :644-670
[4]   Role for a bidentate ribonuclease in the initiation step of RNA interference [J].
Bernstein, E ;
Caudy, AA ;
Hammond, SM ;
Hannon, GJ .
NATURE, 2001, 409 (6818) :363-366
[5]  
Bièche I, 2000, CLIN CANCER RES, V6, P452
[6]   RNA interference in mammalian cells by chemically-modified RNA [J].
Braasch, DA ;
Jensen, S ;
Liu, YH ;
Kaur, K ;
Arar, K ;
White, MA ;
Corey, DR .
BIOCHEMISTRY, 2003, 42 (26) :7967-7975
[7]   siRNA function in RNAi: A chemical modification analysis [J].
Chiu, YL ;
Rana, TM .
RNA, 2003, 9 (09) :1034-1048
[8]   Chemical modification of siRNAs to improve serum stability without loss of efficacy [J].
Choung, S ;
Kim, YJ ;
Kim, S ;
Park, HO ;
Choi, YC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 342 (03) :919-927
[9]   Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells [J].
Czauderna, F ;
Fechtner, M ;
Dames, S ;
Aygün, H ;
Klippel, A ;
Pronk, GJ ;
Giese, K ;
Kaufmann, J .
NUCLEIC ACIDS RESEARCH, 2003, 31 (11) :2705-2716
[10]  
Eder P S, 1991, Antisense Res Dev, V1, P141